174 related articles for article (PubMed ID: 29883928)
1. Disulfiram-loaded mixed nanoparticles with high drug-loading and plasma stability by reducing the core crystallinity for intravenous delivery.
Zhuo X; Lei T; Miao L; Chu W; Li X; Luo L; Gou J; Zhang Y; Yin T; He H; Tang X
J Colloid Interface Sci; 2018 Nov; 529():34-43. PubMed ID: 29883928
[TBL] [Abstract][Full Text] [Related]
2. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
Song W; Tang Z; Lei T; Wen X; Wang G; Zhang D; Deng M; Tang X; Chen X
Nanomedicine; 2016 Feb; 12(2):377-86. PubMed ID: 26711966
[TBL] [Abstract][Full Text] [Related]
3. mPEG
Miao L; Su J; Zhuo X; Luo L; Kong Y; Gou J; Yin T; Zhang Y; He H; Tang X
Mol Pharm; 2018 Apr; 15(4):1556-1564. PubMed ID: 29505711
[TBL] [Abstract][Full Text] [Related]
4. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
5. Decreased Core Crystallinity Facilitated Drug Loading in Polymeric Micelles without Affecting Their Biological Performances.
Gou J; Feng S; Xu H; Fang G; Chao Y; Zhang Y; Xu H; Tang X
Biomacromolecules; 2015 Sep; 16(9):2920-9. PubMed ID: 26314832
[TBL] [Abstract][Full Text] [Related]
6. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
7. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
9. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
10. The influence of mPEG-PCL and mPEG-PLGA on encapsulation efficiency and drug-loading of SN-38 NPs.
Gan M; Zhang W; Wei S; Dang H
Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):389-397. PubMed ID: 27043776
[TBL] [Abstract][Full Text] [Related]
11. Enzyme/pH dual stimuli-responsive nanoplatform co-deliver disulfiram and doxorubicin for effective treatment of breast cancer lung metastasis.
Xiao P; Tao X; Wang H; Liu H; Feng Y; Zhu Y; Jiang Z; Yin T; Zhang Y; He H; Gou J; Tang X
Expert Opin Drug Deliv; 2023; 20(7):1015-1031. PubMed ID: 37452715
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes.
Fasehee H; Zarrinrad G; Tavangar SM; Ghaffari SH; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():587-95. PubMed ID: 27040254
[TBL] [Abstract][Full Text] [Related]
13. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy.
Li H; Liu B; Ao H; Fu J; Wang Y; Feng Y; Guo Y; Wang X
J Nanobiotechnology; 2020 Jan; 18(1):4. PubMed ID: 31907045
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
15. Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques.
Zembko I; Ahmed I; Farooq A; Dail J; Tawari P; Wang W; Mcconville C
J Pharm Sci; 2015 Mar; 104(3):1076-86. PubMed ID: 25537972
[TBL] [Abstract][Full Text] [Related]
16. Ionically fixed polymeric nanoparticles as a novel drug carrier.
Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
[TBL] [Abstract][Full Text] [Related]
18. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
